Journal of Medicinal Chemistry

SJR Rank #1,896H-index: 329SJR: 1.726Best quartile: Q1APC: US$4,500
Journal website: aims, scope and author guidelines
Publisher

American Chemical Society

Country

United States

Type

journal

SJR by Edition

2022202500.511.52

Subject Categories

  • Drug DiscoveryQ1
  • Molecular MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Receptor Mechanisms and SignalingSynthesis and biological activitySynthesis and Biological EvaluationChemical Synthesis and AnalysisComputational Drug Discovery MethodsHIV/AIDS drug development and treatmentSynthesis and Characterization of Heterocyclic CompoundsCancer therapeutics and mechanismsClick Chemistry and ApplicationsBiochemical and Molecular Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0800160024003200

Documents per Year

20222025040080012001600

Detailed Information

ISSN

0022-2623, 1520-4804

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

6.84

References per Document

52.71

Coverage

1959-1961, 1963-2026

Scope

The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action. Some specific areas that are appropriate include the following: -Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools. -Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR). Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication. -Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds. -Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition. -Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge. -Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules. -Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds. This may include design, synthesis, and evaluation of novel types of prodrugs. -Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.

Metrics from SCImago Journal Rank 2025. View on SCImago